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Abstract
Light significantly improves alertness during the night (Cajochen, Sleep Med Rev, 11, 
2007 and 453; Ruger et al., AJP Regul Integr Comp Physiol, 290, 2005 and R1413), 
but results are less conclusive at daytime (Lok et al., J Biol Rhythms, 33, 2018 and 589). 
Melatonin and core body temperature levels at those times of day may contribute to dif-
ferences in alerting effects of light. In this experiment, the combined effect of daytime 
exogenous melatonin administration and light intensity on alertness, body temperature, 
and skin temperature was studied. The goal was to assess whether (a) alerting effects of 
light are melatonin dependent, (b) soporific effects of melatonin are mediated via the 
thermoregulatory system, and (c) light can improve alertness after melatonin‐induced 
sleepiness during daytime. 10 subjects (5 females, 5 males) received melatonin (5 mg) in 
dim (10 lux) and, on a separate occasion, in bright polychromatic white light (2000 lux). 
In addition, they received placebo both under dim and bright light conditions. Subjects 
participated in all four conditions in a balanced order, yielding a balanced within‐sub-
ject design, lasting from noon to 04:00 pm. Alertness and performance were assessed 
half hourly, while body temperature and skin temperature were measured continuously. 
Saliva samples to detect melatonin concentrations were collected half hourly. Melatonin 
administration increased melatonin concentrations in all subjects. Subjective sleepi-
ness and distal skin temperature increased after melatonin ingestion. Bright light expo-
sure after melatonin administration did not change subjective alertness scores, but body 
temperature and proximal skin temperature increased, while distal skin temperature de-
creased. Light exposure did not significantly affect these parameters in the placebo condi-
tion. These results indicate that (a) exogenous melatonin administration during daytime 
increases subjective sleepiness, confirming a role for melatonin in sleepiness regulation, 
(b) bright light exposure after melatonin ingestion significantly affected thermoregulatory 
parameters without altering subjective sleepiness, therefore temperature changes seem 
nonessential for melatonin‐induced sleepiness, (c) subjective sleepiness was increased by 
melatonin ingestion, but bright light administration was not able to improve melatonin‐
induced sleepiness feelings nor performance. Other (physiological) factors may therefore 
contribute to differences in alerting effects of light during daytime and nighttime.
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1 |  INTRODUCTION
The suprachiasmatic nucleus (SCN) is the pacemaker of the 
mammalian circadian timing system. Many physiological 
rhythms are regulated by the SCN, like melatonin secre-
tion and core body temperature.1,2 Plasma melatonin rises 
during the evening and peaks at night, while levels are vir-
tually zero during daytime in most people.3 Core body tem-
perature (CBT) peaks in the evening and has its nadir in the 
early morning.4 Correlations between patterns of melatonin 
and CBT have been shown.5,6 Alertness, which is associ-
ated with high levels of environmental awareness, also fluc-
tuates in a circadian manner,7 with lowest levels in the early 
morning, and high levels during daytime. Mutual regula-
tory relationships have been suggested between melatonin, 
CBT, and alertness.6 Light‐induced melatonin suppression 
is associated with decreased sleepiness,8,9 although proba-
bly not at intermediate indoor light levels.10,11 Melatonin 
ingestion increases subjective sleepiness and lowers CBT,12 
but CBT manipulations affect subjective sleepiness at times 
of day when melatonin is virtually absent, suggesting a 
relationship between CBT and sleepiness independent of 
melatonin.13
Alertness is known to affect many functions, such as 
performance, psychological and physiological well‐being, 
caloric intake, and pain sensitivity.14-17 Displaying optimal 
alertness is thus beneficial, and many studies have attempted 
to improve alertness using monochromatic or polychromatic 
light (for review see,18,19). Exposure to light improves alert-
ness during nighttime, when melatonin concentrations are 
usually high and CBT decreases.9-11,16,20-25 However, several 
studies report absence of light‐induced alertness during day-
time, when alertness and CBT levels are high and melatonin 
is absent,18,20,26-40, although other studies  report  contradic-
tory data.10,41,42 These paradoxical findings can be reconciled 
when an alertness ceiling level during daytime is considered, 
which prevents light to further increase alertness. Differences 
in melatonin and CBT levels might contribute to these dis-
similarities in light‐induced alertness.
In the Netherlands, melatonin is sold over the counter 
up until 5  mg units for self‐treatment of sleep and jet‐lag 
problems.43,44 and to induce circadian phase shifts.45,46 
Administration of varying concentrations of exogenous mela-
tonin has resulted in increased levels of subjective sleepiness, 
coinciding with decreased CBT, which is possibly posture‐
dependent.12,47 Sleepiness inducing effects of melatonin have 
been attributed to its ability to pass the blood‐brain barrier 
and affect hypothalamic CBT regulation.48
Exogenous melatonin decreases alertness, but its con-
centration is unaffected by light. By studying the combined 
effects of melatonin and light on alertness, CBT, and skin 
temperature regulation, it can be assessed whether (a) alert-
ing effects of light are melatonin suppression dependent, (b) 
soporific effects of melatonin are mediated via the thermo-
regulatory system, and (c) light‐induced alertness depends 
on melatonin‐induced sleepiness levels during daytime. The 
goal of this experiment was therefore to investigate these un-
derlying relationships using exogenous melatonin and bright 
light exposure in combination.
2 |  MATERIALS & METHODS
Subjects (5 female, 5 male) were recruited via posters and fly-
ers distributed within the University of Groningen and mouth‐
to‐mouth advertisement. Participants aged 20‐30 years gave 
written informed consent and received financial compensa-
tion for participation. The protocol, questionnaires, and con-
sent forms were approved by the medical ethics committee 
of the University Medical Center Groningen (NL61863.042) 
and were in agreement with the Declaration of Helsinki 
(2013). All participants were students, reported no health 
problems (assessed via an in‐house developed general health 
questionnaire), were intermediate chronotypes (Munich 
Chronotype Questionnaire,49 mid‐sleep on free days cor-
rected for sleep debt on work days (MSFsc) between 3.88 and 
6.17), and did not report sleep problems  (Pittsburgh Sleep 
Quality Index < 6.50). Exclusion criteria were as follows: (a) 
chronic medical conditions or the need for (sleep) medica-
tion use, including melatonin, (b) shift work 3 months before 
participation, (c) having travelled over multiple time‐zones 
within 2  months before participation, (d) smoking, (e) ex-
cessive use of alcohol (>3 consumptions per day), (f) use of 
(recreational) drugs in the last year, (g) a body mass index 
outside the range of 18‐27, and (h) inability to complete 
Ishihara color blindness test51 without errors. Participant 
characteristics are described in Table S1.
The experiment was conducted in April and May 2018, 
with local time expressed as GMT  +  2. Subjects arrived at 
the human isolation facility of the University of Groningen at 
11:30 am, where they stayed in individual rooms in dim light 
(DL, Figure 1). Participants were equipped with DS1922L 
Ibuttons (Thermochron) for measuring skin temperature on 
the forehead (Tforehead), navel (Tnavel), right and left subclavic-
ular regions (Tsubclavicular), hand palms (Thands), underneath the 
feet (Tfeet), and in the pulp of the first toe (Ttoes). An Actiheart 
K E Y W O R D S
alertness, body temperature regulation, daytime, human, light, melatonin, placebo
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monitor (CamNTech) was attached to the left chest to measure 
heart rate. Participants were seated at a desk in a semi‐recum-
bent position. The protocol started with 1 hour of habituation. 
At 01:00 pm, participants were given either a placebo (empty 
gelatin capsule) or melatonin pill (identical gelatin capsule filled 
with 5  mg time release melatonin, Melatomatine; Vemedia). 
90  minutes after placebo or melatonin intervention, partici-
pants either completed the experiment in DL or were exposed 
to bright light (BL) for 90 minutes. Test sessions to assess alert-
ness were completed half hourly from 12:00 pm onwards. Each 
participant received the placebo and melatonin intervention in 
DL and BL and therefore participated four times. Conditions 
were imposed in balanced order and participation was separated 
by at least 1 week. Subjects were instructed to maintain a sta-
ble sleep‐wake rhythm throughout the experiment and were re-
minded of this 2 days before participation. Subjects participated 
on the same day of the week and were blinded to the melatonin 
or placebo intervention, rendering a balanced, single‐blind 
within‐subject design where subjects were their own control.
At the start of a test session, saliva was collected using 
Sarstedt Salivettes with a cotton swab (Sarstedt BV). 
Subsequently, participants placed a CBT pill (e‐Celsius 
Performance, BodyCap, 60‐second sampling interval with 
±0.2°C accuracy and 0.1°C variability level) under the 
tongue to measure temperature underneath the tongue 
(Ttongue). Participants completed the Karolinska Sleepiness 
Scale (KSS),52 followed by a 5‐minute auditory psychomotor 
vigilance task (PVT,53 E‐prime version EP2Pro2.0.10.242). 
After completion, participants removed the CBT pill. Skin 
temperature (60  seconds sampling interval, 0.0625°C reso-
lution, and 0.5°C accuracy) and heart rate (15 seconds sam-
pling interval) were measured continuously.
Dim and bright polychromatic white light was delivered 
by a modified Philips Energy Up light (HF3419/02; Philips, 
Figure S1 and Table S2). The light was placed at a distance of 
20 cm, generating 2000 lux (BL) or 10 lux (DL, by covering 
the lamp with neutral density filters) measured at eye level.
For every individual, PVT anticipation errors occurred 
when a reaction time was shorter than the average of all test 
sessions ‐ two standard deviations, and omission errors oc-
curred when a reaction time exceeded the average reaction 
time of all test sessions +  two standard deviations. Skin 
temperature outliers, defined as values where absolute 
consecutive temperature change exceeding 2°C, were 
omitted. Distal (Tdistal) skin temperature was calculated as 
the average temperature of Thands and Tfeet. Proximal skin 
temperature (Tproximal) was defined as Tsubclacivular, and the 
distal‐proximal gradient (TDPG) was calculated as Tdistal 
minus Tproximal.54 Data of heart rate measurement was an-
alyzed using Actiheart software (version 4.0.116) and can 
be found in Figure S2. Results of Ttongue measurements 
were averaged per test session when temperatures reached 
an asymptote.
All data were z‐transformed per individual. To assess ef-
fects of melatonin administration on alertness, data after mel-
atonin or placebo administration were expressed relative to 
measurements at 01:00 pm. To determine effects of the light 
intervention, data collected during the last three test sessions 
were expressed relative to data collected at 2:30  pm. Skin 
temperature data were averaged over 5 minutes prior to both 
interventions. A 5‐minute running average was calculated to 
smooth short‐term fluctuations. Saliva samples were stored 
at −20°C until analysis, when samples were defrosted and di-
luted, ranging from 0 to 500 times, resulting in values within 
the range of the standard assay curve. Dilution curves were 
tested for linearity. Radioimmunoassay (RIA) analysis (RK‐
DSM2; Bühlmann Laboratories AG) was used to determine 
melatonin concentrations (0.5 pg/mL detection limit, 13.1% 
intra‐assay variation).
Linear models were constructed in RStudio (version 
1.0.136) with subjective sleepiness, PVT performance, 
Ttongue, skin temperature, and heart rate measurements as 
dependent variables. Continuous data were grouped in half‐
hourly bins. Independent variables were time of day and 
intervention. Fixed effects consisted of time of day (as cat-
egorical variable), intervention, and the interaction term. 
Critical two‐sided significance level alpha was 0.05 for all 
statistical tests.
F I G U R E  1  Schematic representation of the experimental design. The protocol lasted from 12:00 am to 04:00 pm and comprised of an hour of 
habituation, followed by the placebo or melatonin intervention and subsequent dim or bright light exposure
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F I G U R E  2  Time course of melatonin concentrations. Concentrations were determined by half‐hourly saliva samples, before and after 
placebo/melatonin administration. All data represent mean (black dots) ± standard error of the mean (gray), N = 10 per group
F I G U R E  3  Effects of melatonin and light on sleepiness, Ttongue, and slowest reaction times. (A) Original data. (B) Z‐transformed data. (C) 
Effects of melatonin in the dim and bright light group. (D) Effects of light during the interval after placebo or melatonin administration. Data in C 
and D data are expressed relative to values at 13:00. E and F data are expressed relative to values at 14:30. DL data are depicted in orange (placebo) 
and dark blue (melatonin). BL data are yellow (placebo) and light blue (melatonin). All data represent mean ± standard error of the mean, N = 10 
per group, except for panel D, in which N = 9 per group
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3 |  RESULTS
Administration of exogenous melatonin resulted in in-
creased salivary melatonin concentrations (F1,114  =  11.55, 
P = 1.26e‐6), which peaked approximately 1.5 hours after 
administration (Figure 2C and 2D, see Figure S3 for indi-
vidual data). Bright light exposure did not alter melatonin 
concentrations, neither after placebo (F1,49 = 0.63, P = 0.43) 
nor melatonin (F1,49 = 0.042, P = 0.84) ingestion. Melatonin 
levels decreased to preadministration levels before the start 
of the light intervention in one subject, this subject was there-
fore excluded from determining light intervention effects.
In the first 90  minutes after melatonin administration, 
there was a significant increase in subjective sleepiness, 
without a significant change in Ttongue and performance 
(Figure 3C and Table 1). Bright light exposure did not affect 
performance and subjective sleepiness after placebo or mel-
atonin ingestion, nor did it affect Ttongue after placebo inges-
tion. After melatonin administration however, BL exposure 
significantly increased Ttongue (Figure 3D and Table 1). There 
were no significant effects of melatonin or light administra-
tion on other output measures of performance, such as antic-
ipation‐ or omission errors (P > 0.05, data not shown).
Melatonin administration increased temperature measured 
in Thands and TDPG (Figure 4C and Table 2). Other skin tem-
perature parameters, such as Ttoes, Tfeet, Tsubclavicular, Tnavel, and 
Tforehead were unaffected by melatonin administration. BL ex-
posure after placebo ingestion significantly increased Thands 
and TDPG, while Tdistal and TDPG were significantly decreased 
after melatonin administration, with an increase in Tproximal.
4 |  DISCUSSION
Light induces significant improvements in alertness during 
nighttime, but similar effects are difficult to demonstrate during 
the day. Differences in melatonin and core body temperature lev-
els at those times of day might contribute to different responses 
in alertness. The goal of this experiment was to assess whether 
(a) alerting effects of light are melatonin suppression dependent, 
(b) these effects were mediated via the thermoregulatory system, 
and (c) light‐induced alertness depended on (melatonin‐induced) 
sleepiness levels during daytime. Melatonin administration dur-
ing daytime increased salivary melatonin concentrations to 
supra‐pharmacological levels, which coincided with decreased 
subjective alertness, implicating a role for melatonin in alert-
ness regulation. Decreased alertness was paralleled by increased 
Tdistal and TDPG, indicating a role for thermoregulation in sleepi-
ness inducing effects of melatonin. However, bright light ex-
posure after melatonin ingestion increased Tproximal and Ttongue 
and decreased Tdistal, suggesting that light is able to counteract 
thermoregulatory effects of exogenous melatonin. Importantly, 
subjective sleepiness was not significantly altered by bright light 
exposure. Thermoregulatory processes therefore seem not di-
rectly related to alerting effects of light. Subjective sleepiness 
was increased by melatonin ingestion, but bright light admin-
istration did not affect subjective sleepiness nor performance; 
therefore, light cannot restore melatonin‐induced sleepiness.
In our subjects, 5 mg melatonin administration resulted in 
peak levels between 600 and 8000 pg/mL, leading to levels 
30‐400 times higher than maximum endogenous concentra-
tions.55 Underlying relationships between melatonin, alertness, 
and temperature suggested here may therefore not reflect reg-
ulatory relationships under natural circumstances. However, 
exogenous melatonin was necessary to investigate underlying 
relationships. Relatively high concentrations were applied to 
maximize chances of significant results. Although salivary 
melatonin levels were high throughout the experiment, we 
cannot exclude the possibility that some of the effects reported 
here were also mediated through metabolites of melatonin, 
which include N(1)‐acetyl‐N(2)‐formyl‐5‐methoxykynur-
amine (AFMK), N(1)‐acetyl‐5‐methoxy‐kynuramine (AMK), 
6‐hydroxymelatonin, and 6‐sulfatoxy melatonin.56 The cur-
rent experiment reveals acute effects of melatonin and light on 
alertness independent of clock manipulations, since both mela-
tonin and light were administrated during relatively unrespon-
sive parts of the respective human phase response curves.57,58
Regulatory relationships between melatonin and alertness 
have been suggested.8,47,59-61   The current study shows that 
exogenous melatonin during daytime leads to a significant in-













F P F P F P
Subjective sleepiness 1,114 114 <0.001 1,49 0.94 0.33 0.10 0.75
Ttongue 1,114 1.27 0.29 1,49 0.22 0.64  7.77 0.008
Performance 1,114 0.42 0.73 1,49 1.99 0.30 1.10 0.30
P‐values that reached significant are indicated in bold for optimal clarity 
T A B L E  1  Statics of melatonin and 
light effects on sleepiness, Ttongue, and 
performance. Values from linear mixed 
models on z‐transformed data
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peak in salivary melatonin concentration. Melatonin receptors 
have been found in the cortex and thalamus, which are areas that 
have been associated with hypnotic effects of melatonin.62-64 
Endogenous melatonin production only occurs during darkness, 
indicating that in diurnal animals, melatonin may signal the op-
timal time for sleep65 and therefore induces sleepiness.66,67 One 
F I G U R E  4  Effects of melatonin and light on skin temperatures. (A) Original data. (B) Z‐transformed data. (C) Effects of melatonin in the 
dim and bright light group. (D) Effects of light during the interval after placebo or melatonin administration. Data in C and D data are expressed 
relative to values at 13:00. E and F data are expressed relative to values at 14:30. DL data are depicted in orange (placebo) and dark blue 
(melatonin). BL data are in yellow (placebo) and light blue (melatonin). All data represent mean ± standard error of the mean, N = 10 per group, 
except for panel D, which includes N = 9 subjects
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of the distinct functions of melatonin in humans is priming of 
sleep‐associated brain activation patterns,67 as it provides infor-
mation about environmental light conditions and time of day.66 
The relatively fast sleepiness inducing effects of melatonin sug-
gest that this might be a direct physiological consequence,68 in-
dependent of melatonin's action as zeitgeber signal.69,70
There are multiple mechanisms by which exogenous mela-
tonin can influence sleepiness. Melatonin is highly lipophilic, 
and it easily passes the blood‐brain barrier.48 Binding sites for 
melatonin have been found in hypothalamic areas associated 
with thermoregulatory processes.64,71,72 Secretion of mela-
tonin, modulated by the SCN, influences CBT levels.73,74 Heat 
(re)distribution from the core to extremities occurs by blood 
transport through proximal and distal skin regions. MT‐1 
melatonin receptors, with vasoconstrictive properties, are lo-
cated in precapillary smooth muscles in proximal and distal 
skin regions while MT2‐receptors, which cause vasodilation, 
are located in arteriovenous anastomoses (AVAs) in distal 
skin regions.75-77 Melatonin might therefore also affect skin 
temperature locally. Since melatonin affects temperature reg-
ulation on multiple levels and changes in body temperature 
correlate to altered alertness, it has been suggested that mel-
atonin induces sleepiness via influencing body temperature.78 
In our experiment, melatonin administration did not result in 
a significant decrease in Ttongue, although subjective sleepiness 
increased. However, it has been claimed that subjective sleep-
iness is mainly influenced by changes in Tdistal.76 In our study, 
Tdistal increase was paralleled by increased subjective sleepi-
ness, indicating that melatonin may indeed induce sleepiness 
through thermoregulatory effects. Temperature effects after 
BL exposure occurred without significantly altering subjective 
sleepiness scores, indicating that soporific effects of melatonin 
may not depend on thermoregulation after all, as has been indi-
cated by others.79 A decrease of 1°C in Tdistal has been reported 
to significantly decrease subjective sleepiness,76 while light 
decreased Tdistal with approximately 0.5°C in our study. It is 
therefore possible that temperature changes due to light expo-
sure were not extensive enough to change sleepiness.
Our study did not demonstrate alerting effects of light 
after placebo ingestion, indicating that light under these cir-
cumstance does not induce alertness during daytime, con-
firming previous observations.33 This emphasizes differences 
between night and day, since alerting effects of light during 
the night have been reported (reviews in Ref.18,19). A possi-
ble explanation is based on high levels of daytime alertness, 
causing a possible ceiling.80 Exogenous melatonin ingestion 
was able to increase subjective sleepiness, removing a poten-
tial ceiling of maximal alertness during daytime and allow-
ing for alertness improvement by light. Since there were no 
significant effects of light on feelings of alertness, even after 
inducing additional sleepiness by exogenous melatonin, it is 
possible that (a) melatonin might not have reduced alertness 
sufficiently, therefore the ceiling of alertness might not have 
decreased sufficiently for alerting effects of light to occur, (b) 
a ceiling effect does not explain the lack of alerting effects 
of light during daytime, or (c) light cannot induce alertness 
when melatonin concentrations are high. Since subjective 
sleepiness scores after melatonin administration are similar 
to those reported during the late evening, when alerting ef-
fects of light have been found,21 it is unlikely that ceiling ef-
fects explain discrepancies between night and day. Imaging 
studies have shown clear differences in brain activity patterns 
between melatonin‐ and sleep deprivation‐induced sleep-
iness.67 Melatonin administration induces changes in brain 
activity patterns resembling patterns seen during sleep, while 
sleep deprivation does not. Underlying neuronal mechanisms 
therefore differ. Studies investigating alerting effects of light 
during daytime after sleep deprivation found significant ef-
fects41 while several studies in rested individuals did not for 
a review see.18,19 Sleep deprivation alters sleep pressure, sug-
gesting that these levels are important for alerting effects of 
light.67 Alerting effects of light have been found after exoge-
nous melatonin administration in the evening, indicating that 
light can induce alertness while melatonin levels are high, 
supporting the notion that other (physiological) factors, such 





Effect of light 
after placebo 
ingestion
Effect of light 
after mela-
tonin ingestion
F P F P F P
Tforehead 1,114 0.00 0.99 1,49 2.25 0.14 1.52 0.22
Tsubclavicular 1,114 1.99 0.12 1,49 2.21 0.14 9.93 0.002
Tnavel 1,114 0.14 0.94 1,49 0.00 0.95 0.02 0.88
Thands 1,114 4.83 0.004 1,49 10.22 0.002 3.94 0.04
Tfeet 1,114 0.64 0.56 1,49 0.17 0.68 0.00 0.98
Ttoes 1,114 0.51 0.67 1,49 0.55 0.46 8.30 0.005
TDPG 1,114 7.00 <0.001 1,49 6.30 0.01 6.75 0.01
P‐values that reached significant are indicated in bold for optimal clarity 
T A B L E  2  Statics of melatonin and 
light effects on skin temperatures. Values 
from linear mixed models on z‐transformed 
data
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of light.81 Although subjective measures and most physiolog-
ical measures reflect a significant increase in sleepiness, per-
formance remained unaffected by both melatonin and light 
intervention. This is in contrast with other studies, which 
report a decreased performance after oral melatonin admin-
istration.59,68,82,83 Cognitive performance tasks might not al-
ways accurately reflect alertness19,84 since performance does 
not correlate with validated subjective measures of alertness 
or temperature parameters that are associated with sleepiness. 
Correlations between subjective alertness and physiological 
measures of alertness might even be stronger compared to the 
relationship with performance tasks.85
In conclusion, 5 mg oral melatonin ingestion during day-
time causes a significant increase in distal skin temperature 
and subjective sleepiness, without affecting performance. 
Bright light exposure after melatonin ingestion does not re-
duce subjective sleepiness, but does increase body tempera-
ture and proximal skin temperature, while decreasing distal 
skin temperature. Melatonin is unlikely to induce sleepiness 
via the thermoregulatory system, since temperature levels 
can be restored without affecting alertness. Through which 
mechanisms melatonin does induce sleepiness, remains un-
known. As alerting effects of light after exogenous mela-
tonin administration have been determined in the evening, 
dissimilarities in alerting effects of light between night and 
day might be caused by different mechanisms underlying 
feelings of sleepiness, possibly due to differences in (physi-
ological) parameters, such as sleep pressure levels.
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